Language Translation
  Close Menu

Communicable Disease Reporting


COVID-19 Lab Reporting Guidance Update: COVID-19 lab results that are not sent electronically, including point-of-care test (POC) results, are no longer required to be reported to the Indiana Department of Health (IDOH), effective immediately. Laboratories and testing sites that submit results via electronic lab reporting (ELR) are still required to report SARS-CoV-2 results to IDOH (HL7 or CSV files), per the Indiana Communicable Disease (CD) Rule (410 IAC). The POC REDCap platform used for submitting COVID-19 test results will be closed.

The following document covers the change in greater detail:

Requirements for Laboratory Reporting of COVID-19 Test Results

Communicable disease reporting changes went into effect April 1.

In March 2023, the Indiana Department of Health (IDOH) announced changes to Indiana’s Communicable Disease (CD) Rule (410 IAC), including streamlined timeframes for reporting and updates to reportable diseases. Indiana Code Title 16 (Health 16-41-2-1) was amended in 2019. This amendment allows the IDOH to publish and update the list of reportable communicable diseases and control measures on the IDOH website. External documents have been created to house this information, which will allow for updates and changes to be made more easily in the future.

The following documents cover the changes in greater detail:

  1. Indiana Reportable Disease List for Healthcare Providers and Hospitals
  2. Indiana Reportable Result/Pathogen List for Laboratories
  3. Summary of Reporting Changes Document
  4. Frequently Asked Questions Document (updated June 2, 2023)
  5. Local Health Department Webcast Slides

Indiana Reportable Disease List for Healthcare Providers and Hospitals

Indiana Reportable Result/Pathogen List for Laboratories

  • Report Immediately on Suspicion

    How to Report

    For immediate reporting call: (317) 233-7125 (weekdays 8:15 a.m. to 4:45 p.m. EST) or (317) 233-1325 (after hours)

    Please also report via electronic laboratory reporting.

    For facilities unable to submit via ELR, please fax reports to 317-234-2812.

    • Bacillus anthracis
    • Burkholderia mallei
    • Burkholderia pseudomallei
    • Clostridium botulinum
    • Corynebacterium diphtheriae
    • Eastern equine encephalitis virus
    • Francisella tularensis
    • Hepatitis, viral, type B, pregnant woman (acute and chronic) or perinatally exposed infant
    • Measles virus
    • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    • Neisseria meningitidis, invasive disease
    • Novel influenza A
    • Poliovirus
    • Rabies virus
    • Rubella virus
    • SARS-associated coronavirus (SARS-CoV)
    • Smallpox (variola) virus
    • Viral hemorrhagic fever, filoviruses
      • Ebola virus
      • Marburg virus
    • Vibrio cholerae O1, O139, or toxigenic
    • Viral hemorrhagic fever, other
      • Crimean-Congo hemorrhagic fever virus
      • Guanarito virus
      • Junin virus
      • Lassa virus
      • Lujo virus
      • Machupo virus
      • Sabia virus
    • Yersinia pestis

    Further guidance on the second page of the Indiana Reportable Result/Pathogen List for Laboratories

  • Report Within One Working Day

    How to Report

    Report via electronic laboratory reporting.

    For facilities unable to submit via ELR, please fax reports to 317-234-2812.

    • Anaplasma spp.
    • Arboviruses including, but not limited to:
      • Chikungunya virus
      • Dengue virus
      • Jamestown Canyon virus
      • Japanese encephalitis virus
      • La Crosse (California serogroup) viruses
      • Powassan virus
      • St. Louis encephalitis virus
      • Western equine encephalitis virus
      • West Nile virus
      • Zika virus
    • Babesia spp.
    • Bordetella pertussis
    • Borrelia burgdorferi
    • Brucella spp.
    • Campylobacter spp.
    • Candida auris and unusual Candida spp. (Species
      other than C. albicans, C. parapsilosis, C. dubliniensis, C. lusitaniae, C. tropicalis, or C. krusei)
    • Carbapenemase-producing Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii*
    • Chlamydia psittaci
    • Chlamydia trachomatis Lymphogranuloma venereum (LGV) (C. trachomatis serotypes L1, L2, or L3)
    • Clostridium tetani
    • Coccidioides spp.
    • Coxiella burnetii
    • Cryptosporidium spp.
    • Cyclospora cayetanensis
    • Ehrlichia spp.
    • Escherichia coli (E. coli) infection (Shiga toxin-producing (STEC), including but not limited to, E. coli O157, E. coli O157:H7,non-O157 E. coli, and Shiga toxin  detected*
    • Giardia spp.
    • Grimontia hollisae (Vibrio hollisae)
    • Haemophilus ducreyi
    • Haemophilus influenzae, invasive disease*
    • Hantavirus
    • Hepatitis, viral, Type A, Anti-HAV IgM or RNA detected
    • Hepatitis, viral, Type B
    • Hepatitis, viral, Type C
    • Hepatitis, viral, Type Delta
    • Hepatitis, viral, Type E, Anti-HEV IgM and IgG
    • Hepatitis, viral, unspecified
    • Histoplasma capsulatum
    • HIV and related retroviruses
    • Influenza
    • Interferon gamma release assay (IGRA) for tuberculosis (positive results only)
    • Legionella spp.
    • Leptospira spp.
    • Listeria monocytogenes
    • Lymphocytic choriomeningitis virus
    • Mpox (Monkeypox) virus, including Non-variola Orthopox virus and Orthopox virus
    • Mumps virus
    • Mycobacterium leprae
    • Mycobacterium tuberculosis
    • Neisseria gonorrhoeae (list anatomic site to  determine if disseminated infection)*
    • Pandrug-resistant Organisms*
    • Photobacterium damselae (Vibrio damsela)
    • Plasmodium spp.
    • Pneumocystis carinii (Pneumocystis pneumonia)
    • Rickettsia (non-rickettsii spp.)
    • Rickettsia rickettsii
    • Salmonella spp. (non-typhoidal)*
    • Salmonella serotype Paratyphi (Paratyphoid fever)*
    • Salmonella serotype Typhi (Typhoid fever)*
    • SARS-CoV-2
    • Shigella spp.*
    • Streptococcus, group A (Streptococcus pyogenes), invasive disease*
    • Streptococcus pneumoniae, invasive disease*
    • Treponema pallidum
    • Trichinella spiralis
    • Vancomycin-resistant Staphylococcus aureus (VRSA) and Vancomycin  intermediate Staphylococcus aureus (VISA)*
    • Varicella-zoster virus
    • Vibrio spp.
    • West African monkeypox virus
    • Yellow fever virus
    • Yersinia spp., Enterocolitica, Pseudotuberculosis

    * Include antimicrobial susceptibility testing
    Further guidance on the second page of the Indiana Reportable Result/Pathogen List for Laboratories

Additional Resources